ACW.AX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 02:10):

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia...

Stats
Today's Volume	1.15M
Average Volume	3.46M
Market Cap	67.48M
EPS	$0 ( 2024-02-26 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.90
ATR14	$0 (0.00%)

Volume Correlation

Long: -0.05 (neutral)

Short: -0.57 (weak negative)

Signal:(47.793) Neutral

Actinogen Medical Ltd Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Actinogen Medical Ltd Correlation - Currency/Commodity

0.00
( neutral )

Actinogen Medical Ltd Financials

Annual	2023
Revenue:	$4.89M
Gross Profit:	$4.48M (91.70 %)
EPS:	$-0.00570

Q2	2024
Revenue:	$0
Gross Profit:	$-211 968 (0.00 %)
EPS:	$-0.00500

Q4	2023
Revenue:	$3.88M
Gross Profit:	$3.68M (94.73 %)
EPS:	$-0.00180

Q3	2022
Revenue:	$1.94M
Gross Profit:	$1.94M (100.00 %)
EPS:	$-0.000900

Financial Reports:

No articles found.

Actinogen Medical Ltd

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, Alzheimer's disease, depression with cognitive impairment, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.